Phase II study of protracted irinotecan infusion and a low-dose cisplatin for metastatic gastric cancer.
Imamura H, Ikeda M, Furukawa H, Tsujinaka T, Fujitani K, Kobayashi K, Narahara H, Kato M, Imamoto H, Takabayashi A, Tsukuma H.
Imamura H, et al. Among authors: furukawa h.
World J Gastroenterol. 2006 Oct 28;12(40):6522-6. doi: 10.3748/wjg.v12.i40.6522.
World J Gastroenterol. 2006.
PMID: 17072984
Free PMC article.
Clinical Trial.